id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-V-0232-0007,FDA,FDA-2004-V-0232,Letter to Tribal Existance Productions,Other,Letter(s),2012-11-29T05:00:00Z,2012,11,2012-11-29T05:00:00Z,,2024-03-15T11:57:13Z,,0,0,09000064811775a9
FDA-2004-V-0232-0006,FDA,FDA-2004-V-0232,FDA/CDRH Response to Tribal Existance Productions - Approval for Variance,Other,VRA-Approval for Variance,2010-11-03T04:00:00Z,2010,11,2010-11-03T04:00:00Z,,2013-07-27T23:34:38Z,,0,0,0900006480b6f44f
FDA-2004-V-0232-0005,FDA,FDA-2004-V-0232,Tribal Existance Productions - Approval for Variance,Other,VRA-Approval for Variance,2007-09-06T04:00:00Z,2007,9,,,2013-08-11T02:33:25Z,,0,0,0900006480471886
FDA-2004-V-0232-0004,FDA,FDA-2004-V-0232,Tribal Existance Productions - Approval for Variance,Other,VRA-Approval for Variance,2005-10-31T05:00:00Z,2005,10,,,2013-08-11T02:33:25Z,,0,0,0900006480471885
FDA-2004-V-0232-0003,FDA,FDA-2004-V-0232,Tribal Existance Productions - Approval for Variance,Other,VRA-Approval for Variance,2005-07-14T04:00:00Z,2005,7,,,2013-08-11T02:33:25Z,,0,0,0900006480471884
FDA-2004-V-0232-0002,FDA,FDA-2004-V-0232,Acknowledgement Letter to Tribal Existance Productions,Other,ACK-Acknowledgement Letter,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:49:44Z,,0,0,0900006480471883
FDA-2004-V-0232-0001,FDA,FDA-2004-V-0232,Acknowledgement Letter to Tribal Existance Productions,Other,ACK-Acknowledgement Letter,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:49:44Z,,0,0,0900006480471880